QUOTIENT LIMITED

QTNT
Real-time Estimate Quote. Real-time Estimate  - 07/15 02:57:10 pm
8.33USD +5.18%
Business Summary
Healthcare
Healthcare Services
 Healthcare Equipment & Supplies
  Medical Equipment, Supplies & Distribution
   Diagnostic & Testing Substances
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Its antisera products contain antibodies used to identify blood group antigens. Its antisera products are monoclonal antibodies manufactured from master cell lines it owns. Its reagent red blood cells products are composed of human red blood cells formulated to enable the identification of blood group antibodies. The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).

Number of employees : 418 people.
Sales per Business
20192020
USD
(in Million)
%USD
(in Million)
%
Product 28.6798.4% 31.6096.8%
Other 0.4691.6% 1.063.2%
Sales per region
20192020
USD
(in Million)
%USD
(in Million)
%
United States 14.7550.6% 17.8354.6%
France 6.5022.3% 7.1121.8%
Japan 3.8513.2% 4.3313.3%
Other Foreign Countries 4.0313.8% 3.3910.4%
Managers
Name Title
Franz Walt Chief Executive Officer & Director
Heino von Prondzynski Chairman
Edward Farrell Chief Operating Officer
Peter Buhler Chief Financial Officer
Thomas A. Bologna Independent Director
Frederick Stanislaus Hallsworth Independent Director
Brian McDonough Independent Director
Zubeen Shroff Independent Director
John Wilkerson Independent Director
Sarah A. O'Connor Independent Director
Shareholders
Name Equities %
Perceptive Advisors LLC 13,289,054 16.5%
Polar Capital LLP 7,610,634 9.48%
Galen Collaborative Capital 7,336,786 9.14%
Highbridge Capital Management LLC 4,164,297 5.19%
Cormorant Asset Management LP 3,161,500 3.94%
ClearBridge Investments LLC 3,052,476 3.80%
TimesSquare Capital Management LLC 2,922,700 3.64%
Credit Suisse Securities (USA) LLC (Broker) 2,732,332 3.40%
ClearBridge LLC 2,525,704 3.14%
Farallon Capital Management LLC 2,500,000 3.11%
Company contact information
Quotient Ltd.
B1, Business Park Terre Bonne
Route de Crassier 13
Eysins, Vaud 1262

Phone : +41.22.716.9800
Web : http://www.quotientbd.com
Sector Diagnostic & Testing Substances
1st jan.Capi. (M$)
QUOTIENT LIMITED-16.72%638
BIOMÉRIEUX58.03%16 836
DIASORIN S.P.A.50.09%10 813
AUTOBIO DIAGNOSTICS CO., LTD.63.93%9 501
10X GENOMICS, INC.16.60%8 745
GUANGZHOU WONDFO BIOTECH CO.,LTD102.82%5 164
MACCURA BIOTECHNOLOGY CO.LTD108.19%4 737
NATERA, INC.43.34%3 802
MYRIAD GENETICS, INC.-57.66%860
CASTLE BIOSCIENCES, INC.25.02%845
TELLGEN CORPORATION34.37%735
TAIDOC TECHNOLOGY CORPORATION90.42%692